Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

British Society ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor ◽

Biologics Register

SAT0038 Factors Predicting Pain and Early Discontinuation of Tumour Necrosis Factor-Alpha-Inhibitors in People with Rheumatoid Arthritis: Results from the British Society for Rheumatology BIOLOGICS Register: Table 1:

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.1549 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 602.2-602

Author(s):

D.F. Mcwilliams ◽

D.A. Walsh

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

British Society ◽

Early Discontinuation ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor ◽

Biologics Register

Drug-specific risk, and associated factors, of vasculitis-like events in patients exposed to tumour necrosis factor alpha inhibitor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA)

The Lancet ◽

10.1016/s0140-6736(16)00442-6 ◽

2016 ◽

Vol 387 ◽

pp. S55

Author(s):

Meghna Jani ◽

William G Dixon ◽

Lianne Kearsley-Fleet ◽

Ian N Bruce ◽

Hector Chinoy ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Associated Factors ◽

British Society ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor ◽

Biologics Register

Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis

Journal of Translational Medicine ◽

10.1186/1479-5876-8-s1-p38 ◽

2010 ◽

Vol 8 (S1) ◽

Author(s):

J Ramirez ◽

J L Fernadez-Sueiro ◽

R Lopez ◽

C Montilla ◽

B Suarez ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

European League Against Rheumatism ◽

Factor Alpha ◽

Alpha Therapy ◽

Necrosis Factor ◽

European League

Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis

Rheumatology ◽

10.1093/rheumatology/41.5.525 ◽

2002 ◽

Vol 41 (5) ◽

pp. 525-530 ◽

Cited By ~ 42

Author(s):

A. M. Al-Heresh

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.106047 ◽

2010 ◽

Vol 69 (4) ◽

pp. 776-777 ◽

Cited By ~ 12

Author(s):

A. R. Fraser ◽

M. E. Perry ◽

A. Crilly ◽

J. H. Reilly ◽

A. J. Hueber ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Matrix Metalloproteinase ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Lipoma Arborescens ◽

Necrosis Factor Alpha ◽

Matrix Metalloproteinase 3 ◽

Factor Alpha ◽

220. Predicting Successful Long-Term Treatment with Tumour Necrosis Factor Alpha Inhibitors in Patients with Psoriatic Arthritis

Rheumatology ◽

10.1093/rheumatology/kev089.107 ◽

2015 ◽

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Term Treatment ◽

Necrosis Factor Alpha ◽

Long Term Treatment ◽

Factor Alpha ◽

THU0418 Obesity Impairs The Response To Tumour Necrosis Factor-Alpha Inhibitors in Psoriatic Arthritis: Results from The DANBIO and ICEBIO Registries

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1777 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 340.1-340

Author(s):

P. Højgaard ◽

B. Glintborg ◽

L.E. Kristensen ◽

T.J. Love ◽

B. Gudbjornsson ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

221. Risk of Cancer in Patients with Severe Psoriatic Arthritis Requiring Tumour Necrosis Factor Alpha Inhibition

Rheumatology ◽

10.1093/rheumatology/kev089.108 ◽

2015 ◽

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Risk Of Cancer ◽

Short-term histopathological response to anti-tumour necrosis factor alpha therapy in patients with ulcerative colitis

10.26226/morressier.596dfd59d462b80292387586 ◽

2017 ◽

Author(s):

Diana-Alexandra Costache

Keyword(s):

Ulcerative Colitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Short Term ◽

Histopathological Response ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Therapy ◽

Faculty Opinions recommendation of A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120210.576363 ◽

2008 ◽

Author(s):

John Atkinson

Keyword(s):

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Cord Factor ◽

Factor Alpha ◽

Necrosis Factor ◽

Granulomatous Response